Expansion Momentum Aspire Allergy & Sinus has rapidly expanded to eight locations in the Greater Austin area, with a recent Georgetown clinic opening in 2026, indicating a scalable footprint and ongoing growth opportunities for partnerships, referrals, and centralized services.

Operational Efficiency A notable improvement in prior authorization turnaround times through the Forus collaboration, cutting from weeks to days, suggests Aspire values streamlined processes and could be open to additional tech-enabled partnerships to further optimize revenue cycle and patient access.

Technology Stack Utilizes a mix of cloud and on-premise solutions (AthenaHealth, Sage Intacct, Windows Server, Nginx) which may present integration opportunities for practice management, electronic health records optimization, revenue cycle enhancements, and security vendors aligned with ambulatory care.

Financial Scale With annual revenue in the 50 to 100 million range and a mid-size employee base, Aspire represents a substantial but approachable target for scalable solutions in patient engagement, appointment optimization, and advanced analytics without enterprise-level complexity.

Care Differentiation Focus on innovative allergy and sinus therapies and patient-centric testing/treatment plans positions Aspire as a potential partner for medical devices, clinical trial collaborations, or specialty pharma partnerships to extend treatment options and improve outcomes.